Inovio Pharmaceuticals Inc. (INO): Price and Financial Metrics
INO Price/Volume Stats
| Current price | $2.27 | 52-week high | $12.33 |
| Prev. close | $2.12 | 52-week low | $1.42 |
| Day low | $2.14 | Volume | 1,163,107 |
| Day high | $2.33 | Avg. volume | 747,808 |
| 50-day MA | $1.86 | Dividend yield | N/A |
| 200-day MA | $3.42 | Market Cap | 83.25M |
INO Stock Price Chart Interactive Chart >
Inovio Pharmaceuticals Inc. (INO) Company Bio
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Inovio leverages its optimized plasmid design and delivery technology to develop DNA medicines to potentially treat and prevent diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. The company has more than 2,000 patients receiving Inovio DNA medicines in more than 7,000 clinical trial applications. Inovio’s corporate headquarters is in Plymouth Meeting, Pennsylvania with research & development and manufacturing facilities in San Diego, California. Dr. J. Joseph Kim serves as the company’s President and Chief Executive Officer.
INO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
INO Price Returns
| 1-mo | 28.98% |
| 3-mo | 16.41% |
| 6-mo | -45.56% |
| 1-year | -77.35% |
| 3-year | -89.55% |
| 5-year | -98.41% |
| YTD | 24.04% |
| 2024 | -70.10% |
| 2023 | -67.31% |
| 2022 | -68.74% |
| 2021 | -43.62% |
| 2020 | 168.18% |